Scarica l'app Stockscreener
17.41
1.42%
-0.25
Pre-mercato:
17.11
-0.30
-1.72%
Precedente Chiudi:
$17.66
Aprire:
$17.88
Volume 24 ore:
350.36K
Relative Volume:
2.16
Capitalizzazione di mercato:
$1.07B
Reddito:
-
Utile/perdita netta:
$-42.21M
Rapporto P/E:
-14.27
EPS:
-1.22
Flusso di cassa netto:
$-33.16M
1 W Prestazione:
-5.02%
1M Prestazione:
-18.64%
6M Prestazione:
+55.59%
1 anno Prestazione:
+42.24%
Intervallo 1D:
$17.25
$18.48
Intervallo di 1 settimana:
$16.97
$19.02
Portata 52W:
$6.595
$22.69
Pulse Biosciences Inc Stock (PLSE) Company Profile
Nome
Pulse Biosciences Inc
Settore
Industria
Telefono
510-906-4600
Indirizzo
3957 POINT EDEN WAY, HAYWARD, CA
Confronta PLSE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
17.41 | 1.07B | 0 | -42.21M | -33.16M | -0.89 |
|
ISRG
Intuitive Surgical Inc
|
521.96 | 185.91B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
226.87 | 65.59B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.89 | 41.99B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
228.69 | 33.57B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
327.56 | 23.72B | 2.88B | 499.60M | 321.60M | 6.74 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-07-27 | Iniziato | Stephens | Overweight |
| 2021-03-11 | Iniziato | Maxim Group | Buy |
| 2021-01-26 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-12 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Pulse Biosciences Inc Borsa (PLSE) Ultime notizie
Pulse Biosciences (NASDAQ:PLSE) Upgraded by StockNews.com to "Sell" Rating - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Rating Increased to Sell at StockNews.com - Defense World
Franklin Resources Inc. Buys New Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
(PLSE) Investment Report - Stock Traders Daily
State Street Corp Has $8.09 Million Stock Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - MarketBeat
State Street Corp Buys 69,696 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences (NASDAQ:PLSE) Trading Down 2.2%Time to Sell? - MarketBeat
Pulse Biosciences: Constructive On Nano-Pulse Assets (NASDAQ:PLSE) - Seeking Alpha
Pulse Biosciences (NASDAQ:PLSE) Stock Rating Upgraded by StockNews.com - Defense World
Pulse Biosciences (NASDAQ:PLSE) Shares Gap UpShould You Buy? - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Upgraded at StockNews.com - MarketBeat
Pulse Biosciences Triggers $66M Warrant Redemption After Stock Price Surge Above $16.50 - StockTitan
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Makes New $588,000 Investment in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
(PLSE) On The My Stocks Page - Stock Traders Daily
Insider Selling: Pulse Biosciences, Inc. (NASDAQ:PLSE) CEO Sells 50,000 Shares of Stock - MarketBeat
Pulse Biosciences' former CEO Barrett Burke Thomas sells $871,000 in stock - Investing.com Canada
Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants - Business Wire
Insider Trading Insights: Key Buys and Sells from Pulse Biosciences, Centene and More - mediahousepress
Pulse Biosciences director Robert Duggan purchases $949,298 in stock By Investing.com - Investing.com UK
Pulse Biosciences, Inc. (NASDAQ:PLSE) Director Buys $949,298.08 in Stock - MarketBeat
Pulse Biosciences director Robert Duggan purchases $949,298 in stock - Investing.com
Pulse Biosciences (NASDAQ:PLSE) Trading 5.3% HigherStill a Buy? - MarketBeat
Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery - BioSpace
Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up on Insider Buying Activity - Defense World
Charles Schwab Investment Management Inc. Has $2.60 Million Stake in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up Following Insider Buying Activity - MarketBeat
Robert Duggan Spends US$972k On Pulse Biosciences Stock - Yahoo Finance
Executive Co-Chairman of Pulse Biosciences Robert Duggan Buys More Stock - Simply Wall St
Insider Buying: Pulse Biosciences, Inc. (NASDAQ:PLSE) Director Purchases 56,054 Shares of Stock - MarketBeat
StockNews.com Upgrades Pulse Biosciences (NASDAQ:PLSE) to Sell - Defense World
Pulse Biosciences director Robert Duggan buys $972,343 in stock By Investing.com - Investing.com Canada
Positive Data Presented for Pulse Biosciences’ nano-PFA Tech - MPO-mag
Top Key Executive Robert Duggan, Pulse Biosciences, Inc.'s (NASDAQ:PLSE) largest shareholder sees value of holdings go down 13% after recent drop - Yahoo Finance
Pulse Biosciences Welcomes New Executive Team Members - MPO-mag
(PLSE) Long Term Investment Analysis - Stock Traders Daily
Pulse Biosciences (NASDAQ:PLSE) Stock Price Up 7.4%What's Next? - MarketBeat
Pulse Biosciences announces CEO departure and interim leadership By Investing.com - Investing.com Australia
Pulse Biosciences announces CEO departure and interim leadership - Investing.com
Pulse Biosciences CEO Resigns Amid Leadership Transition - TipRanks
Pulse Biosciences, Inc. Announces Chief Executive Officer Changes - Marketscreener.com
Pulse Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 - Marketscreener.com
Quest Partners LLC Sells 5,514 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences (NASDAQ: PLSE) Insider Considering Market Purchase of Company StockThe controlling stockholder and Co-Chairman of Pulse Biosciences, Inc. (the “Company”), Robert W. Duggan, has expressed interest in potentially acquiring shares o - Defense World
Pulse Biosciences stockholder plans significant purchase - Investing.com
Pulse Biosciences stockholder plans significant purchase By Investing.com - Investing.com Australia
Pulse Biosciences’ Co-Chairman Plans Major Stock Purchase - TipRanks
Pulse Biosciences (NASDAQ:PLSE) Trading Up 9.3%Should You Buy? - MarketBeat
How to Take Advantage of moves in (PLSE) - Stock Traders Daily
Pulse Biosciences (NASDAQ:PLSE) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Pulse Biosciences Inc Azioni (PLSE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Pulse Biosciences Inc Azioni (PLSE) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| DUGGAN ROBERT W | Director |
Dec 13 '24 |
Buy |
17.18 |
55,256 |
949,298 |
42,328,717 |
| DUGGAN ROBERT W | Director |
Dec 12 '24 |
Buy |
17.13 |
45,404 |
777,771 |
42,273,461 |
| DUGGAN ROBERT W | Director |
Dec 11 '24 |
Buy |
17.35 |
56,054 |
972,344 |
42,228,057 |
| Barrett Burke Thomas | President and CEO |
May 20 '24 |
Buy |
8.56 |
10,000 |
85,600 |
10,000 |
0.05%
1.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):